Skip to content

Life Quality and Mental State in Patients With Breast Cancer

Life Quality and Mental State in Patients With Breast Cancer - a Randomized Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01458457
Acronym
BBK
Enrollment
275
Registered
2011-10-24
Start date
2011-05-31
Completion date
2013-07-31
Last updated
2015-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Randomized pragmatic trial to evaluate the comparative effectiveness regarding disease specific quality of life of an individualized additional complementary medicine treatment in addition to usual care with usual care only in 280 women with breast cancer

Interventions

OTHERIndividualized complementary medicine treatment

An individual treatment plan will be made for each patient that includes one to all of the following treatments: acupuncture, traditional Chinese herbal medicine, enzyme therapy, nutrition advise, Healing Touch, homoeopathy, hyperthermia treatment, infusions, laser therapy, lymphatic drainage, manual therapy, mistel therapy, neural therapy, orthomolecular therapy, osteopathy, phytotherapy, shiatsu

OTHERIndividualized usual care

Patients get usual care from their general practitioners/specialized physicians

Sponsors

Azienda Sanitaria de Sudtirol, Hospital Meran, Meran, Italy
CollaboratorUNKNOWN
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* diagnosed breast cancer * current usual care treatment * willing to refrain from complementary treatment for 6 months in case of randomization into the usual care group * informed consent

Exclusion criteria

* complementary treatment at the Hospital Meran in the last 6 months * no German or Italian language ability * participation in other study

Design outcomes

Primary

MeasureTime frame
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)6 months

Secondary

MeasureTime frameDescription
Subscales of the Functional Assessment of Cancer Therapy - General (FACT-G): physical well-being, social/family well-being, emotional well-being, functional well-being)3, 6 months
Subscale for Breast Cancer of the Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)3, 6 months
Pain, quality of sleep, and nausea (single items of the FACT-B)3, 6 months
Functional Assessment of Chronic Illness Therapy-Fatigue3, 6 months
Survival without relapse6 months
Quality of Life (SF-12 Health Survey)3, 6 months
Functional Assessment of Cancer Therapy-Breast quality of life instrument (FACT-B)3 months
Goal Attainment Scale3 monthsThis outcome measures will only be assessed in the complementary medicine arm
Used complementary Therapies and their frequency6 monthsThis will only be assessed in the complementary medicine arm
Expectations at BaselineBaselineThis will only be assessed in the complementary medicine group
Satisfaction and patient-reported effectiveness3, 6 monthsThis will only be assessed in the complementary medicine arm
Survival6 months
Undesirable Effects and Interactions6 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026